TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
QURE

Uniqure NV

Healthcare · Biotechnology

24.50$ -37.3% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement QURE
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +80.9% +143.6% -47.8% -13.9% -35.5% +415.2% +1,296.8% -79.7% -85.1% +71.2% -40.6%
– -98.5% +11,284.7% -7.3% +8.4% +29.7% +29.2% -79.6% -86.6% +307.7% +34.5% -90.8%
– – +159.7% -316.4% – – -1,265.9% – -79.3% -97.9% +296.9% +63.9%
– +24.0% +41.8% -0.2% +3.4% +26.6% +29.2% +17.3% +37.6% +8.7% -33.1% -2.2%
– +37.0% +4.9% +0.4% +2.7% +32.6% +26.9% +34.3% -4.3% +33.6% -30.6% +28.9%
– +53.2% +35.2% -12.3% +17.0% +29.0% -68.4% +364.7% +30.7% +15.7% -32.3% +4.7%
– – – – – – – – -146.1% – – –
– +27.4% -15.6% +14.0% -12.7% +76.4% +0.4% +95.4% +56.6% +255.1% +53.4% -2.7%
– – – – – – – – -138.5% – – –
– -88.8% +143.0% -117.4% – +1,549.4% -530.9% – -145.7% – +26.4% +131.8%
– – – – – – – – -138.5% – – –
– – – – – – – – -133.9% – – –

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?